The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.
Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients
Open accessAbstract
OBJECTIVE: We studied the clinical and hormonal profiles of patients with central hypothyroidism (CH), the adequacy of levothyroxine (L-T4) treatment and the influence of other pituitary hormone replacement therapies. METHODS: We reviewed medical records of 108 adult patients with child-onset (CO; n=26) or adult-onset (AO; n=82) CH. RESULTS: At diagnosis, the most frequently reported symptoms were fatigue and headaches in AO patients, and growth retardation in CO patients. Serum TSH was normal in a majority of CH patients, low in 8% and elevated in 8%. Serum free thyroxine (fT(4)) was usually reduced, but remained within the low normal range in 28% of the study population (mostly CO patients). Similarly, serum total T(4) (tT(4)), total triiodothyronine (tT(3)) and free T(3) (fT(3)) were found to be within the normal range in significant subsets of patients. Interestingly, the clinical and biochemical characteristics of CH patients with normal f/t T(4) levels were not different from those of the patients with low fT(4) values. The thyroid hormonal profile was not influenced by gender, etiology or by the number of hormone deficiencies. At last evaluation, the mean dose of L-T(4) was 1.6+/-0.5 microg/kg/day and was negatively correlated to current age (P<0.001) but positively correlated to the number of hormone deficiencies (P<0.05). Treatment suppressed TSH in 75% of the patients, induced normal fT(4) in 94%, but normal fT(3) in only 49% of them. Male GH-treated patients and estrogen-treated females needed a higher L-T(4) dose compared with non-treated patients. CONCLUSIONS: fT(4) is clearly the best indicator of CH, but remains in the low normal range in a significant subset of patients, especially in those with CO disease. Adequacy of therapy is mostly reflected by the combination of upper normal fT(4) and low normal fT(3) levels. Pituitary hormone replacement therapy may require an adjustment of T(4) treatment, as female patients under estrogen treatment and male patients under GH treatment will need a higher T(4) dose in order to remain in the euthyroid range.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, serum TSH concentrations are rapidly suppressed in a large portion of CeH patients during the administration of L-T4 [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, mean L-T4 daily doses of 1.2-1.6 μg/kg bw/day were judged sufficient in the large majority of adult CeH patients, with the main aim of achieving a more appropriate metabolic profile [24, 25, 55].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Manifestations of CeH are similar to those of primary hypothyroidism, but they can be masked by coexistent MPHD [1, 24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“Overt CeH is most frequently indicated by the combined findings of low FT4 with low or normal TSH concentrations [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“As in primary hypothyroidism [53], younger CeH patients require higher doses than the older ones [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [25]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Since patients with primary hypothyroidism usually require high-normal or slightly elevated fT4 levels to normalize TSH levels (78), low-normal fT4 levels in hypopituitary patients may suggest the presence of CH.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [78]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinicians are increasingly using newer liquid chromatography-mass spectrometric-based assays with suggested improved sensitivity and reduced interference.This is particularly true for steroids, namely E2, T (104,105), and thyroid and peptide hormones (78,106).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [78]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Clinical longitudinal standards for height and height velocity for North American children
Tanner, J. M., & Davies, P. S. W. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80501-1 · Cited by 1,088
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Mutations in PROP1 cause familial combined pituitary hormone deficiency
Wu, W., Cogan, J. D., Pfäffle, R. W., Dasen, J. S., Frisch, H., O’Connell, S. M., Flynn, S. E., Brown, M. R., Mullis, P. E., Parks, J. S., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-147 · Cited by 562
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 1×
“It remains to be determined whether adding small doses of T3 would be beneficial in CH patients, as has been proposed in primary hypothyroidism ( 22 ).”
BackgroundFish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Ain, K. B., MORI, Y., & Refetoff, S. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-4-689 · Cited by 310
Increased need for thyroxine in women with hypothyroidism during estrogen therapy
Arafah, B. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442302 · Cited by 267
Collu, R., Tang, J., Castagné, J., Lagacé, G., Masson, N., Huot, C., Deal, C., Delvin, E., Faccenda, E., Eidne, K. A., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3918 · Cited by 207
FAGLIA, G., BITENSKY, L., PINCHERA, A., FERRARI, C., PARACCHI, A., BECK-PECCOZ, P., AMBROSI, B., & SPADA, A. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-989 · Cited by 197
Research works printed but not linked: 4
- [7]7. Andersen S, Pedersen KM, Bruun NH & Laurberg P. Narrow indi- vidual variations in serum T4 and T3 in normal subjects: a clue to understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 1068 -1072.
- [10]10. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H et al. Diagnosis of hidden central hypothyroidism in survivors of child cancer. Journal of Clinical Endocrinology and Metabolism 1999 84 4472-4479.
- [12]12. Eds LE Braverman & RD Utiger. Philadelphia: Lippincott, 1996.
- [25]25. Eds LJ DeGroot & JL Jameson. Philadelphia: Saunders, 2001.
Cited by
Sorted by citations
Items 101–134 of 134
Thyroid function in children with short stature accompanied by isolated pituitary hypoplasia
Hu, Y., Zhu, L., Liu, Q., Xue, Y., Sun, X., & Li, G. (2021) · HORMONES · doi:10.1007/s42000-021-00323-0 · Cited by 1
Analysis of the functional state of the thyroid gland in children who underwent COVID-19
Lazareva, M. A., Evseeva, G. P., Викторовна, Р. Е., Vlasova, M. A., Pivkina, T. V., Супрун, С. В., & Лебедько, О. А. (2023) · Bulletin physiology and pathology of respiration · doi:10.36604/1998-5029-2023-88-69-78 · Cited by 1
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
Persani, L., Brabant, G. E., Dattani, M., Bonomi, M., Feldt‐Rasmussen, U., Fliers, E., Grüters, A., Maiter, D. M., Schoenmakers, N. A., & van Trotsenburg, A. S. P. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.3.16 · Cited by 1
Self-citationОсобливості діагностики та лікування вторинного гіпотиреозу
Maslyanko, V. A. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.8.2019.191690 · Cited by 1
Samec, B., Setnikar, G., Gaberšček, S., & Kocjan, T. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1543-8826 · Cited by 1
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_7 · Cited by 1
Παππά, Θ., & Alevizaki, M. K. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_26-1 · Cited by 1
Thyroid Disorders and Hormonal Contraceptives
Behboudi‐Gandevani, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-98777-0_17 · Cited by 1
Novel MTTP Gene Mutation in a Case of Abetalipoproteinemia with Central Hypothyroidism
Acar, S. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0015 · Cited by 1
Petunina, N. A., Trukhina, L. V., & Martirosian, N. S. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.10.000358 · Cited by 1
Rosenquist, K. J., & Kaiser, U. B. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch12 · Cited by 1
Ipotiroidismo centrale: diagnosi, patogenesi e terapia sostitutiva
Persani, L., Ferretti, E., Giavoli, C., & Bonomi, M. (2005) · L Endocrinologo · doi:10.1007/bf03345936
Insuffisance antéhypophysaire acquise de l’adulte : problème diagnostic et thérapeutique
Rodes, M.-L. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.11.014
Endocrine Consequences: Diagnostic Workout and Treatment
Giavoli, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-22297-4_7
The interaction between growth hormone and the thyroid axis
Behan, L., & Agha, A. (2010)
SECONDARY HYPOTHYROIDISM: CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT
Gavrilova, T. A., Моргунова, Т. Б., & Fadeev, V. V. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-3-64-67
Erişkinde Hipopitüitarizmin Tanı ve Tedavisi
Şişman, P., & Gül, Ö. Ö. (2019) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.510272
Lania, A. G., & Beck‐Peccoz, P. (2019) · L Endocrinologo · doi:10.1007/s40619-019-00601-5
Colonic pseudo-obstruction in a patient with Sheehan’s syndrome
Kaur, N., Schubart, U. K., & Mandl, A. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-228936
Luíz, H. V., Manita, I., & Portugal, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_7
Lania, A. G., Giavoli, C., Profka, E., & Beck‐Peccoz, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_17
Persani, L., & Bonomi, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_9
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_8
Persani, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_10
Ormoni tiroidei… attenti a quei due
Carotenuto, R. M., & Bellastella, G. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01124-2
Emerging drug delivery in the treatment of hyperpituitarism and hypopituitarism
Arora, V., Kabra, A., Puri, R., Vyas, G. K., Dua, K., & Dureja, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99616-7.00004-9
Neuroimaging findings and severity of hypopituitarism in a cohort of 78 children
de Castro, M. M. P., & Beserra, I. C. R. (2021) · International Journal of Radiology & Radiation Therapy · doi:10.15406/ijrrt.2021.08.00303
Flannery, C., Rakovac, A., & Boran, G. (2024) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632241298891
Systemic manifestations of hypothyroidism
Pignata, L., Tonacchera, M., & Chiovato, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00206-5
Casiraghi, A., Cattoni, A., & Persani, L. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02659-5
Persani, L., Casiraghi, A., & Bonomi, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00352-6
Abete-Fornara, G., Mangone, A., Lotito, V., Sindaco, G. D., Cremaschi, A., Carosi, G., Mungari, R., Ferrante, E., Bertani, G., Fiore, G., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1736577
Metadata
- Authors
- Alexopoulou, O., Beguin, C., De Nayer, P., & Maiter, D.
- Affiliations
- Cliniques Universitaires Saint-Luc (BE)
- UCLouvain (BE)
- Corresponding author
- Maiter, D
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 150
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2115772710
- Semantic Scholar
- 49bc2de03a96150ced52a1e546d5b35e0ab26c7d
- Cited by
- 135
- References
- 39
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 4 · 2019: 12 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 5 · 2013: 7 · 2012: 6
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- central hypothyroidism, levothyroxine dose, free thyroxine, free triiodothyronine, TSH suppression, growth hormone therapy, estrogen therapy
- MeSH terms
- Adult, Aged, Fatigue, Female, Follow-Up Studies, Growth Disorders, Headache, Humans, Hypothyroidism, Male, Middle Aged, Retrospective Studies, Sexual Dysfunction, Physiological, Thyrotropin, Thyroxine, Age of Onset, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
